|
rohitkachhadiya ☆ Gujarat, 2011-12-13 14:17 (5308 d 16:45 ago) Posting: # 7775 Views: 3,920 |
|
|
Dear All, Kindly suggest me for ANVISA requirement/other regulatory requirement for below mentioned case. Test product strength is 750mg and innovator available is of 250mg. Can we do the BE study of 750mg test (1 unit of test) vs. 3*250mg innovator (3 unit of reference). Regards Rohit |
|
kaushik089 ★ India, 2012-01-02 10:19 (5288 d 20:42 ago) @ rohitkachhadiya Posting: # 7846 Views: 3,219 |
|
|
hello rohit, please mention whether it is an immediate release or modified release dosage? as per my knowledge we consider only IR as 250mg x 3 tab for compensating 750 mg dosage |
|
Jaime_R ★★ Barcelona, 2012-01-02 14:22 (5288 d 16:39 ago) @ kaushik089 Posting: # 7848 Views: 3,193 |
|
|
Hi kaushik089! ❝ ... we consider only IR as 250mg x 3 tab for compensating 750 mg dosage Why? Justification, references? — Regards, Jaime |
|
Helmut ★★★ ![]() Vienna, Austria, 2012-01-02 17:02 (5288 d 14:00 ago) @ kaushik089 Posting: # 7850 Views: 3,145 |
|
|
Dear Kaushik! Agree with Jaime's post. We had never any problems with MR formulations. Of course the reference has to be approved for a o.a.d. regimen exceeding its highest strength.
(as usual)— Dif-tor heh smusma 🖖🏼 Довге життя Україна! ![]() Helmut Schütz ![]() The quality of responses received is directly proportional to the quality of the question asked. 🚮 Science Quotes |

![[image]](img/uploaded/image28.png)
![[image]](img/uploaded/image32.png)
(as usual)![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png)
![[image]](https://static.bebac.at/img/CC by.png)
